EPICS-14: Point of Care Influenzascreening and SARS-CoV-2 (COVID-19) testing in the Emergency Department

EPICS-14: Point of Care Influenzascreening and SARS-CoV-2 (COVID-19) testing in the Emergency Department - EPICS-14

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00019207

Enrollment

3000

Registered

2019-12-23

Start date

2019-12-17

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J10 U07.1

Interventions

Group 1: conventional influenza testing in the central laboratory Group 2: rapid (<30 Min) and early (< 2 hours after admission) influenza testing ´directly in the emergency department

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients attending the Emergency Departments during the study period with any influenza symptom and fever (=38.0°C) will be eligible to participate in the study. No exclusion criteria will be applied.

Exclusion criteria

Exclusion criteria: < 18 years of age

Design outcomes

Secondary

Measure	Time frame
length of hospital stay, in-hospital mortality, proportion of patients tested, ICU admission, proportion of patients with a final diagnosis of influenza or pneumonia, proportion of secondary infections, Aspergillus infections, pneumococci infections, between presentation to the ED and antiviral/antibiotic treatment, time to disposition, admission/discharge rate, medical procedures, laboratory tests performed, transmission rate on other patients. turn-around-time until test result is available. Physician decision making (disposition, medical procedures, antiviral/antibiotic therapy, laboratory parameters).	—

Measure

Time frame

length of hospital stay, in-hospital mortality, proportion of patients tested, ICU admission, proportion of patients with a final diagnosis of influenza or pneumonia, proportion of secondary infections, Aspergillus infections, pneumococci infections, between presentation to the ED and antiviral/antibiotic treatment, time to disposition, admission/discharge rate, medical procedures, laboratory tests performed, transmission rate on other patients. turn-around-time until test result is available. Physician decision making (disposition, medical procedures, antiviral/antibiotic therapy, laboratory parameters).

—

Primary

Measure	Time frame
1. sick days of personnel 2. Proportion of patients treated with antibiotic and antiviral therapy	—

Countries

Germany

Contacts

Public ContactMartin Möckel

Charité Universitätsmedizin BerlinNotfall- und Akutmedizin (CVK, CCM)

martin.moeckel@charite.de004930450553203

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 19, 2026